Table 4.
Per-protocol summary of anti-HPV geometric mean titers at month 7 by race in women 16–26 years of age who received 3 doses of 9vHPV vaccine.
|
Race |
||||||||
|---|---|---|---|---|---|---|---|---|
|
Asian |
Black |
White |
Other |
|||||
| Assay | n | GMT (95% CI) | n | GMT (95% CI) | n | GMT (95% CI) | n | GMT (95% CI) |
| HPV 6 | 763 | 837.4 (793.1, 884.0) |
123 | 935.3 (817.1, 1070.6) |
2415 | 895.4 (868.5, 923.1) |
1020 | 929.0 (886.5, 973.7) |
| HPV 11 | 764 | 594.5 (561.9, 629.0) |
122 | 670.1 (581.8, 771.7) |
2421 | 691.1 (669.5, 713.3) |
1020 | 677.7 (645.4, 711.6) |
| HPV 16 | 792 | 3071.2 (2913.4, 3237.7) |
152 | 3983.9 (3531.7, 4493.9) |
2361 | 3077.8 (2985.2, 3173.4) |
1056 | 3307.7 (3159.9, 3462.3) |
| HPV 18 | 831 | 850.9 (799.4, 905.7) |
170 | 995.0 (866.8, 1142.3) |
2669 | 755.6 (729.7, 782.3) |
1214 | 886.2 (841.6, 933.2) |
| HPV 31 | 858 | 710.7 (667.6, 756.6) |
169 | 786.4 (683.0, 905.5) |
2631 | 619.5 (597.8, 642.1) |
1148 | 725.1 (686.9, 765.4) |
| HPV 33 | 856 | 420.2 (397.1, 444.6) |
189 | 414.6 (367.6, 467.5) |
2733 | 417.1 (404.1, 430.5) |
1278 | 424.0 (404.8, 444.0) |
| HPV 45 | 885 | 281.4 (262.9, 301.3) |
190 | 345.0 (297.9, 399.6) |
2824 | 227.3 (218.8, 236.1) |
1261 | 290.1 (274.1, 307.2) |
| HPV 52 | 788 | 353.8 (332.7, 376.1) |
166 | 444.0 (388.4, 507.5) |
2690 | 388.2 (375.6, 401.4) |
1148 | 381.0 (362.1, 400.8) |
| HPV 58 | 814 | 520.3 (490.5, 551.9) |
161 | 493.1 (431.9, 562.9) |
2720 | 483.6 (468.2, 499.4) |
1123 | 480.8 (457.2, 505.5) |
GMT, geometric mean titer (given in milli-Merck units per milliliter). CI, confidence interval.